173 related articles for article (PubMed ID: 34538748)
1. A Radiomic-based Machine Learning Algorithm to Reliably Differentiate Benign Renal Masses from Renal Cell Carcinoma.
Nassiri N; Maas M; Cacciamani G; Varghese B; Hwang D; Lei X; Aron M; Desai M; Oberai AA; Cen SY; Gill IS; Duddalwar VA
Eur Urol Focus; 2022 Jul; 8(4):988-994. PubMed ID: 34538748
[TBL] [Abstract][Full Text] [Related]
2. Discriminating malignant and benign clinical T1 renal masses on computed tomography: A pragmatic radiomics and machine learning approach.
Uhlig J; Biggemann L; Nietert MM; Beißbarth T; Lotz J; Kim HS; Trojan L; Uhlig A
Medicine (Baltimore); 2020 Apr; 99(16):e19725. PubMed ID: 32311963
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of benign from malignant solid renal lesions using CT-based radiomics and machine learning: comparison with radiologist interpretation.
Wentland AL; Yamashita R; Kino A; Pandit P; Shen L; Brooke Jeffrey R; Rubin D; Kamaya A
Abdom Radiol (NY); 2023 Feb; 48(2):642-648. PubMed ID: 36370180
[TBL] [Abstract][Full Text] [Related]
4. Differentiating Benign From Malignant Cystic Renal Masses: A Feasibility Study of Computed Tomography Texture-Based Machine Learning Algorithms.
Miskin N; Qin L; Silverman SG; Shinagare AB
J Comput Assist Tomogr; 2023 May-Jun 01; 47(3):376-381. PubMed ID: 37184999
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of benign from malignant solid renal lesions with MRI-based radiomics and machine learning.
Massa'a RN; Stoeckl EM; Lubner MG; Smith D; Mao L; Shapiro DD; Abel EJ; Wentland AL
Abdom Radiol (NY); 2022 Aug; 47(8):2896-2904. PubMed ID: 35723716
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Benign and Malignant Solid Renal Masses: Machine Learning-Based CT Texture Analysis.
Erdim C; Yardimci AH; Bektas CT; Kocak B; Koca SB; Demir H; Kilickesmez O
Acad Radiol; 2020 Oct; 27(10):1422-1429. PubMed ID: 32014404
[TBL] [Abstract][Full Text] [Related]
7. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
8. Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid ultrasound morphology.
Moro F; Vagni M; Tran HE; Bernardini F; Mascilini F; Ciccarone F; Nero C; Giannarelli D; Boldrini L; Fagotti A; Scambia G; Valentin L; Testa AC
Ultrasound Obstet Gynecol; 2024 May; ():. PubMed ID: 38748935
[TBL] [Abstract][Full Text] [Related]
9. Conventional and radiomic features to predict pathology in the preoperative assessment of anterior mediastinal masses.
Mayoral M; Pagano AM; Araujo-Filho JAB; Zheng J; Perez-Johnston R; Tan KS; Gibbs P; Fernandes Shepherd A; Rimner A; Simone II CB; Riely G; Huang J; Ginsberg MS
Lung Cancer; 2023 Apr; 178():206-212. PubMed ID: 36871345
[TBL] [Abstract][Full Text] [Related]
10. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
Lee HS; Hong H; Jung DC; Park S; Kim J
Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
[TBL] [Abstract][Full Text] [Related]
12. Characterizing breast masses using an integrative framework of machine learning and CEUS-based radiomics.
Varghese BA; Lee S; Cen S; Talebi A; Mohd P; Stahl D; Perkins M; Desai B; Duddalwar VA; Larsen LH
J Ultrasound; 2022 Sep; 25(3):699-708. PubMed ID: 35040103
[TBL] [Abstract][Full Text] [Related]
13. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
14. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
[TBL] [Abstract][Full Text] [Related]
15. Radiologic-Radiomic Machine Learning Models for Differentiation of Benign and Malignant Solid Renal Masses: Comparison With Expert-Level Radiologists.
Sun XY; Feng QX; Xu X; Zhang J; Zhu FP; Yang YH; Zhang YD
AJR Am J Roentgenol; 2020 Jan; 214(1):W44-W54. PubMed ID: 31553660
[No Abstract] [Full Text] [Related]
16. Automated classification of solid renal masses on contrast-enhanced computed tomography images using convolutional neural network with decision fusion.
Zabihollahy F; Schieda N; Krishna S; Ukwatta E
Eur Radiol; 2020 Sep; 30(9):5183-5190. PubMed ID: 32350661
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.
Nazari M; Shiri I; Hajianfar G; Oveisi N; Abdollahi H; Deevband MR; Oveisi M; Zaidi H
Radiol Med; 2020 Aug; 125(8):754-762. PubMed ID: 32193870
[TBL] [Abstract][Full Text] [Related]
18. Differentiating Oncocytic Renal Tumors from Chromophobe Renal Cell Carcinoma: Comparison of Peak Early-phase Enhancement Ratio to Clinical Risk Factors and Rater Predictions.
Patel HD; Huai K; Elliott N; Thorson DL; Rac G; Picken MM; Quek ML; Bova D; Gupta GN
Eur Urol Open Sci; 2022 Dec; 46():8-14. PubMed ID: 36506255
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of machine learning models based on X-ray radiomics for the classification and differentiation of malignant and benign bone tumors.
von Schacky CE; Wilhelm NJ; Schäfer VS; Leonhardt Y; Jung M; Jungmann PM; Russe MF; Foreman SC; Gassert FG; Gassert FT; Schwaiger BJ; Mogler C; Knebel C; von Eisenhart-Rothe R; Makowski MR; Woertler K; Burgkart R; Gersing AS
Eur Radiol; 2022 Sep; 32(9):6247-6257. PubMed ID: 35396665
[TBL] [Abstract][Full Text] [Related]
20. Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses.
Yap FY; Varghese BA; Cen SY; Hwang DH; Lei X; Desai B; Lau C; Yang LL; Fullenkamp AJ; Hajian S; Rivas M; Gupta MN; Quinn BD; Aron M; Desai MM; Aron M; Oberai AA; Gill IS; Duddalwar VA
Eur Radiol; 2021 Feb; 31(2):1011-1021. PubMed ID: 32803417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
